by Solural Pharma | Nov 16, 2022 | News
Solural Pharma has entered an agreement with Contera Pharma A/S to transfer all proprietary rights for the SOL 707 Morning Akinesia to Contera Pharma.
by Solural Pharma | Dec 25, 2020 | News
Solural Pharma ApS has received a decision to grant a Eurasia patent for the patent “Solid Oral Dosage Form of Lipophilic Compounds”.
by Solural Pharma | Dec 18, 2020 | News
Solural Pharma receives an updated Manufacturing and Importation Authorisation from the Danish Health and Medicines Authority expanding its manufacturing capabilities to also include manufacturing of inhalation products as well as for physical chemical testing of...
by Solural Pharma | Dec 9, 2020 | News
The European Patent office has announced a decision to grant Solural Pharma a European patent “Solid Oral Dosage Form of Lipophilic Compounds”.
by Solural Pharma | Apr 23, 2020 | News
Solural Pharma receives approval from the Danish Health and Medicinal Authorities for handling Cannabis products with the aim to develop new medicinal products.
by Solural Pharma | Dec 19, 2019 | News
Solural Pharma ApS has entered into a cooperation agreement to develop new improved Medicinal Cannabis Products based on the Solural Technology.
